Preventing early seizures after traumatic brain injury
Official title: Assessing Phenytoin and Levetiracetam Efficacy, Cost-Effectiveness, and CYP2C9/SV2A Polymorphism in Early Post-Traumatic Seizures: A Multicentric Prospective Randomized Trial
Run by All India Institute of Medical Sciences, Jodhpur · NCT07072624 · Data updated 2026-11-12
This randomized study will test whether phenytoin, levetiracetam, or placebo best prevent early seizures in people hospitalized with moderate-to-severe traumatic brain injury.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 1260 (estimated) |
| Sponsor | All India Institute of Medical Sciences, Jodhpur Government |
| Locations | 3 sites (Chandigarh, Punjab and 2 other locations) |
| Status | Recruiting |
| Started | July 23, 2025 |
| Main results expected | March 15, 2027 |
| Study ends | March 15, 2028 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT07072624 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people admitted soon after moderate-to-severe TBI (for example GCS <10 or CT evidence of intracranial injury) who are not already on anticonvulsants and are not pregnant.
✕Probably not a fit
Patients who already had seizures before enrollment, are already taking anticonvulsants, are pregnant, or have devastating injuries expected to cause imminent brain death are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, randomized Phase 4 trial that assigns participants to phenytoin, levetiracetam, or placebo to prevent early post-traumatic seizures. The study will also analyze genetic polymorphisms to see whether drug response or seizure risk is affected by patient genetics. Primary outcomes include seizure incidence in the early post-injury period, with secondary outcomes of clinical and functional recovery, safety, and cost-effectiveness. Eligible patients include those with severe blunt TBI (GCS <10), CT-evidence of intracranial injury with higher GCS, or penetrating injuries, while exclusions include pregnancy, prior anticonvulsant use, pre-enrollment seizures, or devastating injury with imminent brain death.
Why it matters
Potential benefit: If successful, the trial could identify the safest and most effective drug to prevent early post-traumatic seizures and help improve recovery after TBI.
How similar studies have gone: Previous research is limited and mixed—older trials suggested some benefit with phenytoin but high-quality head-to-head randomized data and studies incorporating genetics are largely lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients of severe blunt TBI with GCS score less than 10. 2. Patients with GCS of more than 10 in the presence of computed tomographic imaging findings consistent with brain injury: subarachnoid hemorrhage \[SAH\], subdural hematoma \[SDH\], epidural hematoma \[EDH\], intracerebral hemorrhage \[ICH\], or diffuse axonal injury \[DAI\], depressed skull fracture. 3. Patients with penetrating injury. Exclusion Criteria: 1. Females of childbearing age with urine pregnancy test positive. 2. Devastating brain injury with expected or confirmed brain death within 48 hours of hospital admission, 3. Prehospital use of anticonvulsants 4. Development of seizures before enrolment.
Where it's running
-
Postgraduate Institute of Medical Education & Research
Chandigarh, Punjab, India Recruiting -
AIIMS Jodhpur
Jodhpur, Rajasthan, India Recruiting -
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow, Uttar Pradesh, India Recruiting
Study contacts
- Principal investigator: Dr Apinderpreet Singh Additional Professor, MCh Neurosugery — Post Graduate Institute of Medical Education and Research, Chandigarh
- Study coordinator: Dr Jaskaran Singh Gosal Associate Professor, MCh Neurosurgery
- Email: jhsgosal_87@hotmail.com
- Phone: 91 6283475891
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
-
Propranolol for Severe Traumatic Brain Injury in the ICU
A randomized, triple-blind trial tests whether propranolol helps adults with moderate to severe TBI in the ICU.
-
ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
-
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS
This study tests whether 40 HBOT sessions can change blood biomarkers in veterans with traumatic brain injury and persistent symptoms, and whether PTSD affects those biomarker changes.
-
Sleep patterns to help predict waking from brain injury
Doctors are testing whether brain activity during sleep can help predict when a person with a serious brain injury will regain awareness.
-
Recovery after coma from serious brain injury or illness
This observational study will follow adults who are unconscious due to a serious brain illness or injury to see what medical, neurological, psychological, and social factors are linked with recovery over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.